CliffBio
small molecule

RANITIDINE HYDROCHLORIDE

RANITIDINE HYDROCHLORIDE

Loss of exclusivity—loss of exclusivity
CompanyTolmar →See this company's full patent-cliff portfolio

Drug detail

Brand nameRANITIDINE HYDROCHLORIDE
Active ingredientRANITIDINE HYDROCHLORIDE
StrengthEQ 15MG BASE/ML
Dosage formSYRUP
RouteORAL
ModalitySmall molecule
FDA approvalNovember 2010
Marketing statusDISCN

More from Tolmar

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

RANITIDINE HYDROCHLORIDE patent cliff — loss of exclusivity — | CliffBio